secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001437749-23-020539
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics adopts 2023 equity plan (455,169 shares) and amends bylaws
----------------------------------------------------------------------------

- Board approved 2023 Equity Incentive Plan, reserving 455,169 shares of common stock.
- Plan replaces expired 2013 plan; includes 10-year term and annual automatic share increases.
- Bylaw amendment permits stockholder action by written consent with minimum vote required.
- Bylaw amendment allows chairman to adjourn stockholder meetings in absence of quorum.
- Company intends to seek stockholder ratification of the plan in the near future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774923020539/0001437749-23-020539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774923020539/arch20230724_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-020539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer